What the Sunscreen Scares Actually Found

Sunscreen is one of the few products in your bathroom with randomized-trial evidence that it prevents cancer. It's also the target of a steady stream of alarming headlines. Both things deserve a closer look.

Sunscreen occupies an unusual place in health. Very few consumer products have been tested in a randomized controlled trial and shown to prevent cancer in humans. Sunscreen has. Yet over the past few years it has been battered by headlines about chemicals seeping into the bloodstream, carcinogens turning up in the bottle, hormones being disrupted, and vitamin D being blocked. Surveys now find a meaningful slice of younger adults who believe sunscreen is more dangerous than the sun itself.

That's a strange outcome for a product with this much evidence behind it, and it's worth untangling, because the fears aren't all baseless and the reassurances aren't all honest. Some of the scary studies are real. What they actually found, though, is usually narrower and less frightening than the headline suggested. The useful exercise is to separate what sunscreen is proven to do from what it's merely accused of doing.

What we're actually protecting against

Ultraviolet radiation from the sun comes in two bands that reach the skin. UVB drives sunburn and directly damages DNA. UVA penetrates deeper, generating reactive molecules that damage DNA indirectly and drive much of what we recognize as photoaging. Both contribute to skin cancer, the most common cancer in humans by a wide margin, and UV exposure is its main modifiable cause.

Sunscreens block this radiation two ways. Mineral filters—zinc oxide and titanium dioxide—sit on the skin and mostly scatter and absorb UV. Chemical (organic) filters such as avobenzone, oxybenzone, and octocrylene absorb UV and convert it to a small amount of heat. Nearly all of the controversy concerns the chemical filters. None of it concerns whether UV damages skin, which is not in dispute.

The evidence that it works

The centerpiece is the Nambour Skin Cancer Prevention Trial, run in a sun-drenched town in Queensland, Australia, a region with among the highest skin cancer rates in the world. Beginning in 1992, researchers randomly assigned 1,621 adults to either apply broad-spectrum SPF 15+ sunscreen daily to the head, neck, arms, and hands, or to use sunscreen at their own discretion. This is the only randomized trial of sunscreen for skin cancer prevention, which makes it the strongest evidence available.

Over the roughly five-year intervention, daily users developed about 40% fewer squamous cell carcinomas than the discretionary group. Basal cell carcinoma, the other common non-melanoma skin cancer, was not significantly reduced.

The melanoma result came later and is the one worth dwelling on. Researchers tracked the same participants for a decade after the trial ended. In that follow-up window, 11 new invasive-capable melanomas appeared in the daily sunscreen group versus 22 in the discretionary group—a halving of the rate (hazard ratio 0.50, 95% CI 0.24 to 1.02). That result just missed the conventional threshold for statistical significance, with the reduction most pronounced for invasive melanoma. It is not airtight proof, and it's the only trial of its kind, so it shouldn't be oversold. But a randomized halving of melanoma incidence, persisting years after people stopped applying, is a serious finding for the deadliest common skin cancer.

There's a second outcome this audience will care about. Using the same Australian population, a 2013 trial published in Annals of Internal Medicine measured skin aging directly, with micro-topographic impressions of the back of the hand. After four and a half years, adults assigned to daily sunscreen showed 24% less photoaging than the discretionary group (relative odds 0.76, 95% CI 0.59 to 0.98). Daily beta-carotene supplements, tested in the same study, did nothing. Regular sunscreen is one of the few interventions with randomized evidence that it slows visible skin aging, not just cancer.

A fair reading includes the limits. The Nambour participants were overwhelmingly fair-skinned adults in an extreme-UV environment, using an SPF 15 product by today's standards. The effect sizes might differ in other skin types, latitudes, and formulations. Even so, this is a stronger evidence base than almost any other everyday preventive habit can claim.

Beyond the headlines: the four scares

Set the benefits beside the fears, one at a time:

"Sunscreen chemicals get into your blood." True, and we know it because the FDA ran the studies. In two trials published in JAMA in 2019 and 2020, healthy volunteers applied chemical sunscreens under maximal-use conditions, and all six filters tested showed up in plasma above 0.5 nanograms per milliliter, with oxybenzone the highest and fastest. Alarming as that sounds, the 0.5 ng/mL figure is not a danger line. It's a regulatory threshold: below it, a systemically absorbed drug can skip certain additional safety studies; above it, the agency asks for more data. Crossing it means "we need more information," not "this is harmful." The FDA said as much and explicitly advised people to keep using sunscreen. The studies measured absorption, not injury, no toxic effect was demonstrated, only presence in blood.

The GRASE limbo. This is the technical version of the same story. In a 2019 proposed rule, the FDA judged only the two mineral filters, zinc oxide and titanium dioxide, to be "generally recognized as safe and effective" (GRASE) on current data. Two old ingredients, PABA and trolamine salicylate, were deemed not GRASE and pulled from the U.S. market. The remaining dozen chemical filters, including oxybenzone and avobenzone, were placed in an in-between category: not enough data to confirm safety, so more is required. That's easy to misread as "the FDA thinks these are unsafe." It doesn't. It means these older ingredients entered the market before modern absorption testing existed, and the paperwork never caught up. Absence of evidence is not evidence of harm—though it's also not a clean bill of health, which is a fair source of unease.

Benzene in the bottle. In 2021, the independent lab Valisure reported finding benzene, a known human carcinogen with no safe exposure level, in dozens of sunscreen and after-sun products. This one is real and worth taking seriously, but the nature of the problem is specific. Benzene is not a sunscreen ingredient. It's a manufacturing contaminant, likely entering through petroleum-derived components such as aerosol propellants and certain raw materials, and it can also form as the chemical filter octocrylene degrades over time. Contamination was wildly inconsistent, varying from batch to batch within the same brand, and concentrated in aerosol sprays. The findings triggered recalls of more than 25 million products across major brands including Neutrogena, Aveeno, Coppertone, and Banana Boat. The takeaway isn't that sunscreen is poison; it's that spray formulations carry a manufacturing-quality risk that lotions largely avoid.

Hormone disruption. The concern here centers on oxybenzone, which in laboratory and animal studies has shown weak hormone-like activity. The catch is dose and species. Much of the evidence comes from rodents, fish, or cell cultures exposed to concentrations far beyond what human skin application produces, and human studies have not established a clinical effect at real-world exposures. It's a legitimate open question rather than a demonstrated harm, enough to justify choosing a different filter if it bothers you, not enough to justify sunburn.

There's also a persistent myth worth retiring. Does sunscreen cause vitamin D deficiency? A 2019 systematic review in the British Journal of Dermatology concluded that routine, real-world sunscreen use is unlikely to meaningfully lower vitamin D levels, partly because people apply far less than the amount used in lab studies, and a 2025 Australian randomized trial was designed specifically to test daily high-SPF use over a full year. If low vitamin D is a genuine concern for you, the answer is a blood test and, if needed, a supplement—not skipping sun protection.

The story the headlines missed

While the coverage fixated on whether existing filters are dangerous, the more consequential problem is that Americans have been stuck with an outdated menu. The United States allows about 16 UV filters; Europe permits roughly 30, including newer molecules that are more photostable and better at covering the UVA range. No genuinely new sunscreen filter had been added to the U.S. list since 1999, because sunscreens are regulated as over-the-counter drugs and the approval pathway effectively stalled.

That is finally shifting. In December 2025, the FDA proposed adding bemotrizinol—a broad-spectrum filter long used in Europe, Australia, and Asia, to the approved U.S. list at concentrations up to 6%. It's photostable, covers both UVA and UVB, and in a maximal-use trial showed minimal systemic absorption, with only a handful of the nearly 300 plasma samples registering any measurable amount. A late-2025 law, the SAFE Sunscreen Standards Act, also pushed the agency to accept real-world evidence in evaluating filters. The practical implication is that many of the absorption and irritation concerns attached to older chemical filters may be engineered away by newer ones—if regulation keeps moving.

What to actually do

Strongly supported. Use a broad-spectrum sunscreen of SPF 30 or higher as one part of sun protection, alongside shade, clothing, and timing. The cancer-prevention and anti-aging benefits shown in randomized trials are real, and they matter most for anyone fair-skinned, with a personal or family history of skin cancer, or spending significant time outdoors. Applying enough and reapplying is where most people fall short: real-world application is typically a fraction of the amount used to certify the SPF on the label, which means the protection you get is usually well below the number on the bottle.

Reasonable preferences, for peace of mind rather than proven danger. If the absorption and hormone questions bother you, mineral sunscreens built on zinc oxide or titanium dioxide sidestep them almost entirely, those filters barely penetrate intact skin, and they're a sensible default for children and sensitive skin. Choosing lotions over aerosol sprays addresses the benzene-contamination risk and the tendency to under-apply sprays, and it avoids inhaling the product. None of this is because chemical filters have been shown to harm people; it's a rational way to act under uncertainty.

Worth tracking. Get to know your own skin and have suspicious or changing spots checked, since early detection remains the single most powerful lever for skin cancer outcomes. If vitamin D is a worry, measure it rather than guessing.

Risks, limits, and who should take extra care

Sunscreen is not a force field, and treating it as permission to bake in the sun undermines the point. It works as one layer of protection, not a substitute for shade and clothing during peak hours.

A few specifics matter. Some chemical filters, avobenzone and oxybenzone among them, can cause contact allergy or irritation in susceptible people; mineral formulas are usually better tolerated. Standard guidance is to keep infants under six months out of direct sun and rely on shade and clothing rather than sunscreen. And skin cancer is not only a fair-skinned concern: people with darker skin develop it too, often diagnosed later and at worse stages, so protection and skin checks still apply even when burning is rare. The strongest efficacy data come from a fair-skinned population, which is a genuine gap, not a reason for anyone to opt out.

For the environmentally minded, oxybenzone and octinoxate have been restricted in places such as Hawaii over concerns about coral reef damage. The human health case for avoiding them is unsettled; the option to choose mineral or newer filters exists regardless.

The bottom line

Strip away the headlines and the asymmetry is clear. The evidence that sunscreen prevents squamous cell carcinoma and slows skin aging comes from randomized trials, and the evidence that it halves melanoma, while not definitive, points the same direction. The evidence that it harms people is, so far, evidence of blood absorption without demonstrated injury, a contamination problem tied mainly to sprays, and hormone signals seen at doses humans don't experience. Those are reasons to prefer certain formulations and to keep studying the older filters. They are not reasons to trade a proven benefit for the certainty of ultraviolet damage.

The most defensible move is also the simplest: pick a broad-spectrum product you'll actually use—mineral or a lotion if the chemical-filter questions weigh on you—apply enough of it, and combine it with shade and clothing. The molecule you're unsure about is a smaller risk than the sun you're sure about.

Evidence grade: Strong for benefit, weak-to-unproven for harm. Randomized human trials support cancer and photoaging prevention; the safety concerns rest largely on absorption data, contamination incidents, and preclinical findings, none of which have established human harm at real-world use.

-Sources

1. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354(9180):723–729. https://pubmed.ncbi.nlm.nih.gov/10475183/

2. Green AC, Williams GM, Logan V, Strutton GM. Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up. J Clin Oncol. 2011;29(3):257–263. https://ascopubs.org/doi/10.1200/JCO.2010.28.7078

3. Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and Prevention of Skin Aging: A Randomized Trial. Ann Intern Med. 2013;158(11):781–790. https://www.acpjournals.org/doi/10.7326/0003-4819-158-11-201306040-00002

4. Matta MK, Zusterzeel R, Pilli NR, et al. Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA. 2019;321(21):2082–2091. https://jamanetwork.com/journals/jama/fullarticle/2733085

5. Matta MK, Florian J, Zusterzeel R, et al. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA. 2020;323(3):256–267. https://jamanetwork.com/journals/jama/fullarticle/2759002

6. US Food and Drug Administration. Sunscreen Drug Products for Over-the-Counter Human Use (Proposed Rule, 2019; Proposed Administrative Order OTC000008, 2021). https://www.federalregister.gov/documents/2019/02/26/2019-03019/sunscreen-drug-products-for-over-the-counter-human-use

7. Valisure LLC / Kucera K, et al. Independent Sun Care Product Screening for Benzene Contamination. Environ Health Perspect. 2022;130(3):037702. https://ehp.niehs.nih.gov/doi/10.1289/EHP10386

8. Neale RE, Khan SR, Lucas RM, et al. The effect of sunscreen on vitamin D: a review. Br J Dermatol. 2019;181(5):907–915. https://doi.org/10.1111/bjd.17980

9. US Food and Drug Administration. FDA proposes bemotrizinol as a new over-the-counter sunscreen active ingredient (Proposed Order, December 2025). https://www.fda.gov/drugs/news-events-human-drugs/

Medical Disclaimer

This article is provided for general educational and informational purposes only. It is not medical advice and is not a substitute for diagnosis, treatment, or guidance from a qualified healthcare professional who knows your individual history and skin cancer risk. Individual needs vary with skin type, medical history, medications that increase sun sensitivity, and sun exposure. Nothing here should be used to self-diagnose a skin lesion or to delay evaluation of a changing or suspicious spot. Consult a physician or board-certified dermatologist about your personal sun-protection and skin-screening plan, and seek prompt medical attention for any concerning skin changes.